Literature DB >> 12391601

Death and survival of neuronal cells exposed to Alzheimer's insults.

Takako Niikura1, Yuichi Hashimoto, Hirohisa Tajima, Ikuo Nishimoto.   

Abstract

Neuronal cell death is the central abnormality occurring in brains suffering from Alzheimer's disease (AD). The notion that AD is a disease caused by loss of neurons points toward suppression of neuronal death as the most important therapeutic target. Nevertheless, the mechanisms for neuronal death in AD are still relatively unclear. Three known mutant genes cause familial AD (FAD): amyloid precursor protein, presenilin 1, and presenilin 2. Detailed analysis of cytotoxic mechanisms of the FAD-linked mutant genes reveals that they cause neuronal cell death at physiologically low expression levels. Unexpectedly, cytotoxic mechanisms vary depending on the type of mutations and genes, suggesting that various mechanisms for neuronal cell death are involved in AD patients. In support of this, activity-dependent neurotrophic factor, basic fibroblast growth factor, and insulin-like growth factor-I can completely protect neurons from beta-amyloid (A beta) cytotoxicity but exhibit incomplete or little effect on cytotoxicity by FAD mutant genes. By contrast, Humanin, a newly identified 24-residue peptide, suppresses neuronal cell death by various FAD mutants and A beta, whereas this factor has no effect on cytotoxicity from AD-irrelevant insults. Studies investigating death and survival of neuronal cells exposed to AD insults will open a new horizon in developing therapy aimed at neuroprotection. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391601     DOI: 10.1002/jnr.10354

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

1.  Construction of a eukaryotic expression plasmid of Humanin.

Authors:  Ben-yan Luo; Xiang-ming Chen; Min Tang; Feng Chen; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2005-01       Impact factor: 3.066

Review 2.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

3.  Protective effects of humanin on okadaic Acid-induced neurotoxicities in cultured cortical neurons.

Authors:  Jinfeng Zhao; Dan Wang; Lingmin Li; Wenhui Zhao; Ce Zhang
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

4.  Humanin Does Not Protect Against STZ-Induced Spatial Memory Impairment.

Authors:  Kourosh Negintaji; Asadollah Zarifkar; Rasoul Ghasemi; Maryam Moosavi
Journal:  J Mol Neurosci       Date:  2015-03-06       Impact factor: 3.444

Review 5.  Humanin: after the discovery.

Authors:  Takako Niikura; Tomohiro Chiba; Sadakazu Aiso; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

Review 6.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

7.  Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress.

Authors:  Adi R Bachar; Lea Scheffer; Andreas S Schroeder; Hiromi K Nakamura; Laura J Cobb; Yun K Oh; Lilach O Lerman; Richard E Pagano; Pinchas Cohen; Amir Lerman
Journal:  Cardiovasc Res       Date:  2010-06-18       Impact factor: 10.787

8.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis.

Authors:  Maaria Ikonen; Bingrong Liu; Yuichi Hashimoto; Liqun Ma; Kuk-Wha Lee; Takako Niikura; Ikuo Nishimoto; Pinchas Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-15       Impact factor: 11.205

10.  SH3-binding protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase.

Authors:  Yuji Takeshita; Yuichi Hashimoto; Mikiro Nawa; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.